Posted by Michael Wonder on 20 Aug 2019
Brand name drug prices rising at slower pace, lower amounts
20 August 2019 - Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to.
After years of frequent list price hikes, many drugmakers are showing some restraint, according to the analysis of drug prices provided by health information firm Elsevier.
In the first seven months of 2019, drugmakers raised list prices for brand-name prescription medicines by a median of 5%. That’s down from about 9% or 10% over those months the prior four years, the AP found. From January through July this year, there were 4,483 price hikes, down 36% from that stretch in 2015.
